Long-term trends in thyroid carcinoma: A population-based study in Olmsted County, Minnesota, 1935-1999

Mayo Clinic Proceedings

Volumn 80, Issue 6, 2005, Pages 753-758

  Burke, James P ^a   Hay, Ian D ^a   Dignan, Fiona ^b   Goellner, John R ^a   Achenbach, Sara J ^a   Oberg, Ann L ^a   Melton III, L Joseph ^a  

^a Mayo Clinic College of Medicine   (United States)

^b UNIVERSITY OF ABERDEEN   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; ATOMIC BOMB; CANCER INCIDENCE; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IONIZING RADIATION; MAJOR CLINICAL STUDY; MALE; PAPILLARY CARCINOMA; POPULATION RESEARCH; RADIATION INJURY; SEX DIFFERENCE; THYROID CARCINOMA; UNITED STATES;

EID: 20044376123     PISSN: 00256196     EISSN: None     Source Type: Journal    
DOI: 10.1016/s0025-6196(11)61529-2     Document Type: Article

References (26)

1. Wermers RA, Khosla S, Atkinson EJ, Hodgson SF, O'Fallon WM, Melton LJ III. The rise and fall of primary hyperparathyroidism: a population-based study in Rochester, Minnesota, 1965-1992. Ann Intern Med. 1997;126:433-440.
2. Tisell LE, Carlsson S, Fjalling M, et al. Hyperparathyroidism subsequent to neck irradiation: risk factors. Cancer. 1985;56:1529-1533.
3. Beard CM, Heath H III, O'Fallon WM, Anderson JA, Earle JD, Melton LJ III. Therapeutic radiation and hyperparathyroidism: a case-control study in Rochester, Minn. Arch Intern Med. 1989;149:1887-1890.
4. Fujiwara S, Sposto R, Ezaki H, et al. Hyperparathyroidism among atomic bomb survivors in Hiroshima. Radiat Res. 1992;130:372-378.
5. Schneider AB, Gierlowski TC, Shore-Freedman E, Stovall M, Ron E, Lubin J. Dose-response relationships for radiation-induced hyperparathyroidism. J Clin Endocrinol Metab. 1995;80:254-257.
6. Langsteger W, Koltringer P, Wolf G, et al. The impact of geographical, clinical, dietary and radiation-induced features in epidemiology of thyroid cancer. Eur J Cancer. 1993;29A:1547-1553.
7. Mangano JJ. A post-Chernobyl rise in thyroid cancer in Connecticut, USA. Eur J Cancer Prev. 1996;5:75-81.
8. Gilbert ES, Tarone R, Bouville A, Ron E. Thyroid cancer rates and 131I doses from Nevada atmospheric nuclear bomb tests. J Natl Cancer Inst. 1998;90:1654-1660.
9. Hundahl SA. Perspective: National Cancer Institute summary report about estimated exposures and thyroid doses received from iodine 131 in fallout after Nevada atmospheric nuclear bomb tests. CA Cancer J Clin. 1998;48:285-298.
10. Hundahl SA, Fleming ID, Fremgen AM, Menck HR. A National Cancer Data Base report on 53,856 cases of thyroid carcinoma treated in the U.S., 1985-1995. Cancer. 1998;83:2638-2648.
11. Verby JE, Woolner LB, Nobrega FT, Kurland LT, McConahey WM. Thyroid cancer in Olmsted County 1935-1965. J Natl Cancer Inst. 1969;43:813-820.
12. Hay ID, Freeman SL, Bergstralh EJ, Goellner JR, Offord K, Kurland LT. Trends in the epidemiology of thyroid cancer through five decades [abstract]. Clin Res. 1987;35:347A.
13. Kurland LT, Molgaard CA. The patient record in epidemiology. Sci Am. 1981;245:54-63.
14. Melton LJ III. History of the Rochester Epidemiology Project. Mayo Clin Proc. 1996;71:266-274.
15. Hedinger CE, Williams ED, Sobin LH. Histological Typing of Thyroid Tumours. 2nd ed. Berlin, Germany: Springer-Verlag; 1988. International Histological Classification of Tumors series.
16. Melton LJ III. The threat to medical-records research. N Engl J Med. 1997;337:1466-1470.
17. Bergstralh EJ, Offord KP, Chu CP, Beard CM, O'Fallon WM, Melton LJ III. Calculating Incidence, Prevalence and Mortality Rates in Olmsted County, Minnesota: An Update. Rochester, Minn: Division of Biostatistics, Mayo Clinic; April 1992. Technical Report Series, No. 49.
18. Frome EL, Checkoway H. Epidemiologic programs for computers and calculators: use of Poisson regression models in estimating incidence rates and ratios. Am J Epidemiol. 1985;121:309-323.
19. Zheng T, Holford TR, Chen Y, et al. Time trend and age-period-cohort effect on incidence of thyroid cancer in Connecticut, 1935-1992. Int J Cancer. 1996;67:504-509.
20. Sabbagh R, Abdel-Misih RZ. An overview of thyroid carcinoma. Del Med J. 1997;69:547-552.
21. Haselkorn T, Bernstein L, Preston-Martin S, Cozen W, Mack WJ. Descriptive epidemiology of thyroid cancer in Los Angeles County, 1972-1995. Cancer Causes Control. 2000;11:163-170.
22. Mulla ZD, Margo CE. Primary malignancies of the thyroid: epidemiologic analysis of the Florida Cancer Data System registry. Ann Epidemiol. 2000;10:24-30.
23. Goodman MT, Yoshizawa CN, Kolonel LN. Descriptive epidemiology of thyroid cancer in Hawaii. Cancer. 1988;61:1272-1281.
24. Surveillance, Epidemiology, and End Results (SEER) Program Public-Use Data (1973-1998). Bethesda, Md: National Cancer Institute, DCCPS, Surveillance Research Program, Cancer Statistics Branch; 2000.
25. Lind P, Langsteger W, Molnar M, Gallowitsch HJ, Mikosch P, Gomez I. Epidemiology of thyroid diseases in iodine sufficiency. Thyroid. 1998;8:1179-1183.
26. Franceschi S, Boyle P, Maisonneuve P, et al. The epidemiology of thyroid carcinoma. Crit Rev Oncog. 1993;4:25-52.